Background <p>Epilepsy affects over 50 million people worldwide, with the majority residing in low- and middle-income countries (LMICs) where access to specialized care is often constrained. Surgical intervention represents a crucial therapeutic modality for patients with medically refractory epilepsy, yet epilepsy surgery remains markedly underutilized in sub-Saharan Africa.</p> Case presentation <p>We report the case of a 10-year-old boy in The Gambia with medically refractory epilepsy characterized by daily drop attacks. Despite optimized and adequately trialed therapy with carbamazepine and sodium valproate, he continued to experience disabling seizures, leading to recurrent head trauma. Computed tomography (CT) and magnetic resonance imaging (MRI) did not reveal an identifiable structural lesion. Given the intractability of seizures and significant associated morbidity, he underwent a corpus callosotomy. The procedure was performed via a standard microsurgical approach and concurrently addressed the resection of traumatic calcified scalp hematomas. The patient’s postoperative recovery was uneventful, and he was discharged on postoperative day 13 and remained seizure-free. At the six-month postoperative follow-up, the patient achieved complete freedom from drop attacks, with generalized tonic–clonic seizures (GTCS) occurring only during periods of antiseizure medication (ASM) interruption.</p> Conclusions <p>This case highlights the feasibility and therapeutic potential of epilepsy surgery in the context of a surgical program within a resource-limited setting. Scaling up access to epilepsy surgery in comparable environments could contribute to mitigating the global epilepsy treatment gap.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

First corpus callosotomy for medically refractory epilepsy in The Gambia: an international cooperation case report and historical review

  • Zsombor T. Gal,
  • Ebrima K. Manneh,
  • Saksham Gupta,
  • Gabrielle A. Luiselli,
  • Makumba Cham,
  • Ancha Ceesay,
  • Mai Nyassi,
  • Yusupha Jobe,
  • Richard Oguocha,
  • Musa Barry,
  • Mary F. Gomez,
  • Malick Jammeh,
  • Oley Bojang,
  • Tida Jagne,
  • Fatoumata Jallow,
  • Adama Njie,
  • Cherno S. Jallow,
  • Mustapha Bittaye,
  • Mariam Joof,
  • Kebba S. Marenah,
  • Yohana C. Sanchez,
  • Maguette Mbaye,
  • Nantenin Doumbia,
  • Sabina Kangakan,
  • Pokua Sarpong,
  • Mhd A. Alkhateeb,
  • Eduardo R. Cobas,
  • Lamin Janneh,
  • John D. Rolston,
  • John N. Jabang

摘要

Background

Epilepsy affects over 50 million people worldwide, with the majority residing in low- and middle-income countries (LMICs) where access to specialized care is often constrained. Surgical intervention represents a crucial therapeutic modality for patients with medically refractory epilepsy, yet epilepsy surgery remains markedly underutilized in sub-Saharan Africa.

Case presentation

We report the case of a 10-year-old boy in The Gambia with medically refractory epilepsy characterized by daily drop attacks. Despite optimized and adequately trialed therapy with carbamazepine and sodium valproate, he continued to experience disabling seizures, leading to recurrent head trauma. Computed tomography (CT) and magnetic resonance imaging (MRI) did not reveal an identifiable structural lesion. Given the intractability of seizures and significant associated morbidity, he underwent a corpus callosotomy. The procedure was performed via a standard microsurgical approach and concurrently addressed the resection of traumatic calcified scalp hematomas. The patient’s postoperative recovery was uneventful, and he was discharged on postoperative day 13 and remained seizure-free. At the six-month postoperative follow-up, the patient achieved complete freedom from drop attacks, with generalized tonic–clonic seizures (GTCS) occurring only during periods of antiseizure medication (ASM) interruption.

Conclusions

This case highlights the feasibility and therapeutic potential of epilepsy surgery in the context of a surgical program within a resource-limited setting. Scaling up access to epilepsy surgery in comparable environments could contribute to mitigating the global epilepsy treatment gap.